Geftinat 250mg Tablet

Geftinat 250 mg Tablet contains Gefitinib, which belongs to the Antineoplastics group. It is indicated in adults for the management of locally advanced or metastatic non-small cell lung cancer (NSCLC) who have activating mutations of the EGFR-TK.

Description

Complete Handbook on Geftinat 250mg Tablet: Usage and Insight

Medicine Geftinat 250mg
Marketed By Natco Pharma Ltd
Active Ingredient Gefitinib (250mg)
Storage Store below 30°C
Consume Type Oral

Geftinat 250mg Tablet – Introduction

Geftinat 250 mg Tablet is prescribed for treating non-small cell lung cancer. This medication is specifically intended for patients whose cancer has metastasized to different body parts, individuals with unusual epidermal growth factor receptor (EGFR) genes, and those who have not undergone any prior cancer treatments.

How Geftinat 250mg Tablet Works: A Closer Look

Geftinat Gefitinib 250 mg Tablet is classified as an anti-cancer drug. It prevents the irregular protein activity that triggers cancer cells to proliferate and divide. Consequently, this drug successfully stops or slows the spread of cancer cells.

Geftinat 250mg Tablet Use

Non-small cell lung cancer

Geftinat 250mg Tablet – The Benefits

Non-small cell lung cancer is a prevalent cancer that impacts individuals, whether smokers or non-smokers. Geftinat 250 mg tablet, is used as a stand-alone treatment or in combination with other drugs to treat non-small cell lung cancer. Given the strength and potential for toxicity of this medicine, it is imperative that you thoroughly examine the benefits and dangers with your healthcare professional. You should avoid alcohol during this treatment and be adequately hydrated by drinking lots of water.
 

Geftinat 250mg Tablet – A Usage Guide

Follow your doctor’s instructions regarding the dosage and duration of this medication. Ingest the tablet whole; do not chew, crush, or break it. Geftinat 250 mg Tablet can be consumed with or without food, although it’s advisable to take it consistently at the same time.

Geftinat 250mg Tablet – Side Effects

The majority of side effects typically do not necessitate immediate medical intervention and tend to resolve as your body acclimates to the medication. However, if these side effects persist or cause you concern, it is advisable to seek advice from your doctor.

Common Side Effects 

  • Diarrhea
  • Dry skin
  • Loss of appetite
  • Nausea
  • Rash
  • Stomatitis (inflammation of the mouth)
  • Vomiting
  • Weakness
  • Weight loss

[Note: Different drugs can cause varying side effects. To get accurate information about a medication’s specific side effects, refer to the official prescribing information for that medication or consult with your healthcare provider.] 

Geftinat 250mg Tablet – A Guide to Safety

Humog 150 HP Injection- A Guide to Safety

warnings

Alcohol

Unsafe

Drinking alcohol while taking a Geftinat 250 mg tablet is not advised.

warnings

Pregnancy

Consult Your Doctor

It is not recommended to take the Geftinat Gefitinib 250 mg pill while pregnant because there is clear evidence that it may harm the growing foetus. If the benefits outweigh the risks, the doctor may very seldom prescribe it if there is a death threat. Please consult your physician.

warnings

Breast feeding

Consult Your Doctor

Using Geftinat, a 250 mg tablet, during nursing is most likely not advised. According to scant human data, the medication can harm the baby if it enters the breast milk.

warnings

Driving

Unsafe

You may get adverse effects with the Geftinat 250mg Tablet that could impair your driving ability.

warnings

Liver

Safe if Prescribed

Patients with liver disease can safely take Geftinat 250 mg tablets. Kindly speak with your physician.
 
warnings

Kidney

Caution
In individuals with severe kidney conditions, Geftinat 250mg Tablet should be used with caution. The dosage could need to be modified. Kindly speak with your physician.

Facts Box

Fact Box

Chemical Group Quinazolinamines
Addictive No
Medication Class Anti Neoplastics
Action Class/Category Tyrosine kinase inhibitors

Swift Advice

  • Geftinat 250 mg tablet is prescribed for locally advanced or metastatic non-small cell lung cancer.
  • It can be taken with or without food, ideally at the same time daily.
  • Avoid using antacids within 2 hours before or 1 hour after taking this medication.
  • Diarrhea is a potential side effect; if it persists or you notice blood in your stools, inform your doctor.
  • Practice reliable contraception during treatment and one month after discontinuing the medicine to prevent pregnancy.
  • Notify your healthcare provider if you experience mouth ulcers, vision changes, a worsening cough, shortness of breath, or breathing issues while on this medication.
  • Your doctor may recommend regular liver function tests during your treatment with this medicine.

Contact us at info@thelotusbiotech.com or +91 98998 96668 for more information.

How does gefitinib work?

Gefitinib works by blocking the signals sent by Tyrosine kinase protein that send signals telling cancer cells to grow.

No, Gefitinib is an oral tyrosine kinase inhibitor against the epidermal growth factor receptor (EGFR). According to a trial, patients receiving gefitinib have improved quality-of-life compared to those receiving chemotherapy, making it an appropriate first-line choice.

Gefitinib is prescribed for the treatment of non small cell lung cancer (NSCLC) that has spread into the surrounding tissues (locally advanced) or to other parts of the body.
As per the Journal of Clinical Oncology, the overall response rate of this medication was 66% (90% CI, 51% to 80%), and the disease control rate was 90%. This is as per the study conducted between February 2006 and May 2007.

Gefitinib is in a class of medications called kinase inhibitors.

The Lotus Biotech is a leading exporter of anti-cancer medications, including Gefitinib 250. Buy geftinat 250 mg tablets in bulk from us by reaching out to our experts at info@thelotusbiotech.com.

Reviews

There are no reviews yet.

Be the first to review “Geftinat 250mg Tablet”

Your email address will not be published. Required fields are marked *